- Douwes FR: Transurethral hyperthermia in prostate cancer: a ten year observation study
- Meggyesházi N et al: Early changes in protein expression releated to modulated electro-hyperthermia
- Acs B and Szasz O: Oncothermia in practice: quality assurance, applications, devices
- Andocs G et al: Oncothermia research at preclinical level
- Roussakow S: Russian Oncothermia Manual
- Okamoto Y et al: Clinical application of Oncothermia against the tumors developed in deep tissue in Veterinary medicine
- Pang CLK: Progress of research of hyperthermia integration with TCM in the treatment of cancer
- Szasz A: “Quo vadis” oncologic hyperthermia?
- Moss R: War against cancer
- Huilgol N et al: Report of the single institute experience in treating head and neck cancer with hyperthermia and radiation as well as chemo-radiation
- Mitagravia N et al: Autoregulation of the brain temperature during whole body hyperthermia
- Vujaskovic Z: Clinical trials in breast and bladder cancer: Thermally enhanced chemosensitization and drug delivery
- Douwes FR: Local and whole body hyperthermia in chemoresistant ovarian cancer
- Kleef R: Application of transurethral prostate hyperthermia in benign and malign prostate hyperplasia and chronic prostatitis
- Roussakow S: Critical analysis of randomized trials on hyperthermia: dubious effect and multiple biases
- Giammaria F et al: Phase II clinical study on relapsed malignant gliomastreated with electro-hyperthermia
- Bicher IH: Hyperfractinated thermoradiotherapy (HTRT) is more effective and less invasive than radiation or chemoradiation in heatable cancers – a meta analysis
- Brenner J: Strategies for the cancer treatment with hyperthermia
- Wehner H: Whole body hyperthermia in water bath: technical-physical aspects and clinical experiences
- Joan VJ et al: Complete responses after hyperthermic ablation by ultrasound guided high intensity focused ultrasound (USgHIFU) plus cystemic chemotherapy (SC) for locally advanced pancreatic cancer
- Assogna M et al: Chemotherapy combined with regional hyperthermia in locally advanced unresectable pancreatic cancer: clinical and anthropological benefits
- Schwartz L et al: New cancer paradigm and new treatment: the example of METABLOC
- Baronzio GF et al: Hypoxia, Immunity, Metabolism and Hyperthermia
- Jing-hong L and Yu Ling X: Electrochemical therapy of tumors
- Hegyi G and Jian L: Low back pain – complex approach of treatment CAM modalities (acupuncture and other type of dry-needling, “Targeted RF non invasive physiotherapy” for low back pain)
- Yimin L et al: Deep regional hyperthermia combined with Traditional Chinese Medicine in treating benign diseases in Clifford Hospital
- Yong sen J et al: Regulation of Tonglian decoction on cell cycle and signal pathway mediated with NF-kB in cell line MGC-803 of gastric carcinoma
- Wei Q et al: A novel dendritic cell therapy with oncothermotherapy mediated by abscopal effect
- Wey S: Infrared WBH for relapse prevention in cancer
- Thaller A: Treatment of a High Grade Glioma (GBM) with four different oncolytic viruses (Parvo HI, VSV, NDV-Nothabene and Sindbis-Virus), elected by the symptoms, delivered via an Intra-arterial Port-a-Cath-System and controlled by repeated MRIs
- Zais O and Szasz A: Lyme disease and oncothermia
- Ballerini M et al: AndroTherm application for “La Peyronie” disease
- Roussakow S: Where, when and why hyperthermia went wrong way?
- Szasz O: Essentials of Oncothermia
- Szasz O: Burden of oncothermia – Why is it special?
- Youngsuk L: Oncothermia application for various malignant diseases
- Tae SJ et al: Cases that respond to Oncothermia monotherapy
- Fiorentini G et al: Abscopal effect: new perspectives in Oncothermia
- Kovago Cs et al: Report of the pilot-study done for the proposed investigation on the possible synergic effect between high dose ascorbic acid application and oncothermia treatment
- Meggyeshazi N et al: Programmed cell death induced by modulated electro-hyperthermia
- Pesti L et al: Treatment of advanced cervical cancer with complex chemoradio – hyperthermia
- Lorencz P and Csejtei A: Experience in the treatment of liver metastases with special reference to the consequences of interruption of long-run treatments
- Andocs G et al: Oncothermia basic research at in vivo level. The first results in Japan
- Coletta D et al: Stabilization of metastatic breast cancer with capacitive hyperthermia plus standard-dose chemotherapy and/or metronomic
- Strauss CA et al: Oncothermia in HIV positive and negative locally advanced cervical cancer patients in South Africa
- Szasz O et al: Oncothermia as personalized treatment option
- Nagy G et al: Deep temperature measurements in oncothermia processes
- Szasz O et al: Modulation effect in oncothermia
- Hegyi G: Synergy between TCM and Oncothermia
- Gallne-Valyi A: Introduction of the international quality management systems by sample of Oncotherm Group
- Skrihar G: Production support by LabView-based data-acquisition systems
- Szigeti GyP et al: Hyperthermia versus Oncothermia: cellular effects in cancer therapy
- Andocs G et al: Bystander effect of oncothermia
- Lee DY et al: Oncothermia with chemotherapy in the patients with small cell lung cancer
- Fiorentini G: Deep electro-hyperthermia with radiofrequencies combined with thermoactive drugs in patients with liver metastases from colorectal cancer (CRC): A phase II clinical study
- Gramaglia A et al: Liposomiated doxarubycyn (LD) and hyperthermia on glioblastoma relapsing after surgery, radiotherapy and two chemotherapy lines: a case report
- Kovago Cs et al: Proposed investigation on the possible synergic effect between high dose ascorbic acid application and oncothermia treatment
- Meggyeshazi N et al: Programmed cell death induced by modulated electro-hyperthermia
- Pesti L et al: Complex treatment of advanced uterine cervix Chemo-radio-thermotherapy case report
- Lorencz P and Csejtei A: Experience in the treatment of liver metastases, with special reference to the consequences of interruption of long-run treatments
- Andocs G et al: Oncothermia basic research at in vivo level. The first results in Japan
- Coletta D et al: Stabilization of metastatic breast cancer with capacitive hyperthermia plus standard-dose chemotherapy and/or metronomic
- Roussakow S: Critical analysis of randomized trials on electromagnetic hyperthermia: doubtful effect and multiple biases
- Strass CA et al: Oncothermia in HIV positive and negative locally advanced cervical cancer patients in South Africa
- Jückstock J et al: Locoregional hyperthermia combined with chemotherapy for metastatic breast cancer patients – preliminary results of the Mammatherm-trial
- Szasz O et al: Oncothermia – personalized treatment option
- Nagy G et al: Deep temperature measurements in oncothermia processes
- Szasz O et al: Oncothermia paradigm
- Szasz O et al: Modulation effect in oncothermia
- Hegyi G et al: Synergy of oncothermia and traditional Chinese medicine
- Gallne-Valyi Anett: Introduction of the international quality management system: Oncotherm Group
- Szasz O and Szasz A: Essence of Oncothermia
- Skrihar G: Production support by LabView-based data-acquisition systems
- Szigeti GyP et al: Hyperthermia versus Oncothermia: cellular effects in cancer therapy
- Andocs G et al: Bystander effect of Oncothermia
- Kim YH et al: Electro-hyperthermia for refractory ovarian cancer patient having bone marrowdepletion as a consequence of long-term chemotherapy: Case report
- Lee DY et al: Hyperthermia in the patients with small cell lung cancer
- Vokalis I et al: Loco regional hyperthermia in Greece: A new treatment modality for treating deep seated tumors. Two years clinical experience from Thessaloniki hyperthermia’s – Oncology operation center – New challenges
- Leckler J: Oncotherm Group Marketing & Sales Strategy
- Acs B: Oncotherm products overview
- Oncothermia.ru: EHY-2000 standard treatment zones
- Oncothermia.ru: Summary Guidelines
- WFCMS: Speciality Committee WFCMS
- Oncotherm: Welcome poster
- Osmanoglu Hospital: Oncology Center Istanbul
- Seong GM: A case of clinically complete remission of lung with hyperthermia and concurrent 5th-line chemotherapy in a disseminated NSCLC patient